SMTI

+ Watchlist + Portfolio

Sanara MedTech Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $34.28
52-Week Range: $16.05 – $35.95
Market Cap: $314.60M
P/E (TTM): —
EPS (TTM): -0.04
Dividend Yield: —

Advanced Metrics

Price/Book: 44.64
PEG Ratio: —
Return on Equity: -1.32%
Return on Assets: 7.64%
Gross Margin: 93.03%
Operating Margin: 6.33%
Profit Margin: -29.15%
Current Ratio: 2.58
Debt/Equity: 6.12
Total Debt: $48.53M
Free Cash Flow: $5.70M
Revenue Growth: 9.00%
Earnings Growth: —
Enterprise Value: $347.70M

SMTI Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$45.84M	$64.99M	$86.67M	$103.12M
Cost of Revenue	$6.36M	$7.85M	$8.14M	$7.52M
Gross Profit	$39.48M	$57.14M	$78.53M	$95.60M
Research & Development	$3.37M	$4.13M	$2.83M	$5.07M
Selling, General & Admin	$45.98M	$56.99M	$71.67M	$78.72M
Operating Expenses	$51.71M	$64.80M	$77.29M	$86.45M
Operating Income	-$12.23M	-$7.67M	$1.24M	$9.15M
EBITDA	-$11.57M	-$289.09K	$6.11M	$10.31M
Pretax Income	-$13.94M	-$4.44M	-$1.94M	-$393.12K
Income Tax	-$5.84M	$0.00	—	—
Net Income	-$7.94M	-$4.30M	-$9.66M	-$37.56M
Diluted EPS	-1.00	-0.52	-1.14	-4.36
Diluted Shares	7.91M	8.28M	8.48M	8.62M

SMTI Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$8.96M	$5.15M	$15.88M	$16.58M
Receivables	$7.00M	$8.53M	$13.55M	$12.00M
Inventory	$3.55M	$4.72M	$2.75M	$3.95M
Current Assets	$20.62M	$19.01M	$33.31M	$33.54M
Total Assets	$61.04M	$73.87M	$88.09M	$72.94M
Current Liabilities	$12.81M	$13.77M	$15.29M	$18.63M
Long-Term Debt	—	$9.11M	$30.69M	$45.97M
Total Debt	$819.22K	$11.79M	$32.29M	$48.19M
Total Liabilities	$19.32M	$29.28M	$49.18M	$67.01M
Retained Earnings	-$23.39M	-$28.04M	-$37.78M	-$75.30M
Shareholders' Equity	$41.83M	$44.83M	$39.40M	$5.94M
Working Capital	$7.81M	$5.24M	$18.02M	$14.92M
Net Debt	—	$4.55M	$14.81M	$29.39M

SMTI Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$5.55M	-$3.25M	-$23.78K	$6.79M
Capital Expenditure	-$747.01K	-$265.25K	-$229.30K	-$4.65M
Free Cash Flow	-$6.30M	-$3.51M	-$253.08K	$2.14M
Depreciation & Amortisation	$2.37M	$3.68M	$4.92M	$3.95M
Stock-Based Compensation	$2.70M	$3.44M	$4.44M	$5.15M
Investing Cash Flow	-$3.51M	-$10.21M	-$6.61M	-$14.97M
Financing Cash Flow	-$627.35K	$9.64M	$17.37M	$8.89M
Net Change in Cash	-$9.69M	-$3.81M	$10.73M	$700.56K

SMTI Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$23.43M	$25.83M	$26.33M	$27.55M	$27.80M
Cost of Revenue	$1.83M	$1.94M	$1.87M	$1.87M	$1.92M
Gross Profit	$21.60M	$23.89M	$24.46M	$25.67M	$25.87M
Research & Development	$950.36K	$1.26M	$1.03M	$2.04M	$759.59K
Selling, General & Admin	$19.13M	$21.55M	$19.88M	$20.08M	$21.88M
Operating Expenses	$20.77M	$23.92M	$21.52M	$22.78M	$23.23M
Operating Income	$825.53K	-$31.35K	$2.94M	$2.89M	$2.65M
EBITDA	$1.82M	$887.40K	$3.69M	$1.39M	$2.78M
Pretax Income	-$620.57K	-$2.02M	$834.49K	-$1.11M	$397.69K
Net Income	-$3.53M	-$2.01M	-$30.41M	-$1.61M	$458.96K
Diluted EPS	-0.41	-0.23	-3.52	-0.19	0.05
Diluted Shares	8.57M	8.61M	8.94M	8.47M	8.99M

SMTI Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$20.69M	$16.96M	$14.94M	$16.58M	$13.59M
Receivables	$11.90M	$12.00M	$12.09M	$12.00M	$13.62M
Inventory	$3.16M	$3.51M	$3.39M	$3.95M	$3.12M
Current Assets	$36.84M	$33.67M	$31.23M	$33.54M	$31.20M
Total Assets	$96.38M	$98.77M	$71.09M	$72.94M	$69.28M
Current Liabilities	$13.28M	$14.88M	$17.36M	$18.63M	$13.70M
Long-Term Debt	$43.40M	$44.22M	$45.09M	$45.97M	$46.23M
Total Debt	$44.72M	$45.45M	$47.39M	$48.19M	$48.37M
Total Liabilities	$59.71M	$63.38M	$64.95M	$67.01M	$62.26M
Retained Earnings	-$41.31M	-$43.29M	-$73.69M	-$75.30M	-$74.50M
Shareholders' Equity	$36.67M	$35.40M	$6.15M	$5.94M	$7.03M
Working Capital	$23.56M	$18.79M	$13.87M	$14.92M	$17.50M
Net Debt	$22.71M	$27.26M	$30.15M	$29.39M	$32.63M

SMTI Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$2.00M	$2.66M	$2.18M	$3.95M	-$2.47M
Capital Expenditure	-$1.72M	-$1.78M	-$1.06M	-$82.16K	-$43.77K
Free Cash Flow	-$3.72M	$879.20K	$1.12M	$3.86M	-$2.51M
Depreciation & Amortisation	$1.12M	$1.11M	$1.04M	$668.40K	$587.25K
Stock-Based Compensation	$1.30M	$1.44M	$1.23M	$1.18M	$1.03M
Investing Cash Flow	-$5.18M	-$3.93M	-$3.42M	-$2.45M	-$43.77K
Financing Cash Flow	$11.99M	-$2.47M	-$774.75K	$139.43K	-$475.22K
Net Change in Cash	$4.81M	-$3.73M	-$2.02M	$1.64M	-$2.98M

Market Snapshot

About

Sanara MedTech is a medical technology company focused on developing and commercializing products for wound care and skincare. The company offers advanced wound care dressings, surgical solutions, and dermatological products for healthcare providers and patients. Sanara markets its products through distribution partners and direct sales to hospitals, wound care centers, and physicians.